Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

3.8K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
3.8K
Autoimmune Disorders01:29

Autoimmune Disorders

2.4K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
2.4K
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

1.6K
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
1.6K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

906
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
906
Other Disorders of Digestive System01:30

Other Disorders of Digestive System

1.7K
The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
1.7K
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

79
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows...
79

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Achieving Health Equity Through Digestive Diseases Research and Scientific Workforce Diversity.

Gastroenterology·2022
Same author

Heterogeneity of Diabetes: β-Cells, Phenotypes, and Precision Medicine: Proceedings of an International Symposium of the Canadian Institutes of Health Research's Institute of Nutrition, Metabolism and Diabetes and the U.S. National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases.

Diabetes·2021
Same author

Opportunities for Research for COVID-19 in the Mission of NIDDK.

Diabetes care·2020
Same author

NIDDK Programs and Emerging Opportunities for Digestive Diseases Research.

Gastroenterology·2015
Same author

Gaps and opportunities in pancreatic disease research.

Pancreas·2013
Same author

Advances in acute and chronic pancreatitis: from development to inflammation and repair.

Gastroenterology·2012

Related Experiment Video

Updated: May 5, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

23.9K

19. Immunologic, gastroenterologic, and hepatobiliary disorders.

Stephen P James1

  • 1Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases/NIH, 6707 Democracy Boulevard, Room 675, Bethesda, MD 20892-5450, USA.

The Journal of Allergy and Clinical Immunology
|February 20, 2003
PubMed
Summary

Gastrointestinal and hepatobiliary disorders often involve the immune system. Understanding their immunopathogenesis is key for diagnosis and developing targeted treatments like infliximab for Crohn's disease.

More Related Videos

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

2.5K
Murine Bilateral Renal Lymphadenectomy
06:31

Murine Bilateral Renal Lymphadenectomy

Published on: December 30, 2025

227

Related Experiment Videos

Last Updated: May 5, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

23.9K
Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

2.5K
Murine Bilateral Renal Lymphadenectomy
06:31

Murine Bilateral Renal Lymphadenectomy

Published on: December 30, 2025

227

Area of Science:

  • Immunology
  • Gastroenterology
  • Hepatology

Background:

  • Many gastrointestinal and hepatobiliary disorders have an immunologic basis, but understanding varies.
  • Celiac disease has identified genetic/environmental factors and specific treatments.
  • Inflammatory bowel disease and sclerosing cholangitis share strong associations and immunologic features crucial for diagnosis.

Purpose of the Study:

  • To explore the immunopathogenesis of gastrointestinal and hepatobiliary disorders.
  • To highlight the diagnostic importance of immunologic features in associated conditions.
  • To review current and novel therapeutic approaches.

Main Methods:

  • Review of existing literature on immunologic gastrointestinal and hepatobiliary disorders.
  • Analysis of genetic, environmental, and animal model contributions.
  • Examination of diagnostic immunologic markers.
  • Assessment of therapeutic strategies, including novel biological agents.

Main Results:

  • Significant advancements in understanding immunopathogenesis for conditions like celiac disease.
  • Animal models have aided research in pernicious anemia and inflammatory bowel disease.
  • Inflammatory bowel disease and sclerosing cholangitis show characteristic immunologic associations.
  • Novel biological agents, such as infliximab for Crohn's disease, represent a therapeutic advance.

Conclusions:

  • The immunologic basis of many gastrointestinal and hepatobiliary disorders is increasingly recognized.
  • Diagnostic immunologic features are critical for specific conditions.
  • While nonselective agents are common, novel biological therapies offer targeted treatment options.